Key Points
- EVP Michael Cuffe sold 1,500 shares of HCA on Feb. 3 at an average price of $498.09 for $747,135, leaving him with 30,003 shares (a 4.76% reduction, ~ $14.94M stake).
- HCA beat quarterly EPS expectations with $8.01 (vs. $7.37 consensus) and gave FY2026 EPS guidance of 29.100–31.500; the company also raised its quarterly dividend to $0.78, and analysts carry a consensus target of $519.71 ("Moderate Buy").
HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) EVP Michael Cuffe sold 1,500 shares of the firm's stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the transaction, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
HCA Healthcare Stock Performance
NYSE HCA opened at $513.26 on Friday. The company's 50-day simple moving average is $480.19 and its two-hundred day simple moving average is $441.12. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $527.55. The company has a market capitalization of $117.12 billion, a price-to-earnings ratio of 18.06, a price-to-earnings-growth ratio of 1.51 and a beta of 1.36.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts' consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the previous year, the firm posted $6.22 earnings per share. HCA Healthcare's revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare's dividend payout ratio is presently 10.15%.
Analyst Ratings Changes
Several brokerages have weighed in on HCA. Jefferies Financial Group raised their target price on shares of HCA Healthcare from $535.00 to $590.00 and gave the company a "buy" rating in a research note on Wednesday, January 28th. Bank of America boosted their target price on HCA Healthcare from $430.00 to $470.00 and gave the stock a "neutral" rating in a research note on Monday, October 27th. Robert W. Baird raised their price target on HCA Healthcare from $423.00 to $450.00 and gave the stock a "neutral" rating in a report on Thursday, December 11th. Royal Bank Of Canada lifted their target price on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 28th. Finally, Barclays raised their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an "overweight" rating in a report on Wednesday, January 28th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $519.71.
Get Our Latest Report on HCA Healthcare
Hedge Funds Weigh In On HCA Healthcare
Institutional investors have recently modified their holdings of the stock. Brighton Jones LLC purchased a new position in HCA Healthcare during the fourth quarter valued at approximately $1,021,000. NewEdge Advisors LLC increased its holdings in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC boosted its holdings in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after buying an additional 33 shares in the last quarter. Ameritas Advisory Services LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth about $153,000. Finally, Wealthcare Advisory Partners LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $218,000. Hedge funds and other institutional investors own 62.73% of the company's stock.
HCA Healthcare Company Profile
(
Get Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
